ArticleJournal of clinical medicine2023

Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn's Patients.

Giuseppe Frieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.